skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialoheptaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)

اصطلاح مرجح

n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

مفهوم‌های اخص

بار

  • -1

فرمول

  • C61H99N4O45R2

بخشی دارد

جرم

  • 1608.441

جرم تک‌ایزوتوپی

  • 1607.55813

اسمایلٓ

  • [C@@]1(O[C@]([C@@H]([C@H](C1)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])(C([O-])=O)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@@H]2O)CO)O[C@@H]3[C@H]([C@H](O[C@@H]([C@@H]3O)CO)O[C@@H]4[C@H]([C@@H](O[C@@H]([C@@H]4O)CO)O[C@H]5[C@@H]([C@H]([C@@H](O[C@@H]5CO)O[C@@H]6[C@H]([C@@H](O[C@@H]([C@@H]6O)CO)O[C@H]7[C@@H]([C@H]([C@@H](O[C@@H]7CO)OC[C@@H]([C@@H](*)O)NC(=O)*)O)O)O)NC(=O)C)O)O[C@H]8[C@H]([C@@H]([C@@H]([C@@H](O8)C)O)O)O)NC(=O)C)O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuNAc-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(1-)
  • a neolactoside IV(3)-alpha-[NeuNAc-alpha-(2->3)-Gal-beta-(1->3)-GalNAc],IV(2)-alpha-Fuc-nLc4Cer
  • blood antigen group type II sialosylgalactosyl-A

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:144653

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD